Hardy Reed’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Sell
4,027
-1,069
-21% -$580K 0.14% 63
2025
Q4
$2.95M Buy
5,096
+16
+0.3% +$9.05K 0.21% 48
2025
Q3
$2.46M Buy
5,080
+20
+0.4% +$9.31K 0.18% 49
2025
Q2
$2.05M Buy
5,060
+2,490
+97% +$1.04M 0.16% 57
2025
Q1
$1.28M Hold
2,570
0.11% 83
2024
Q4
$1.34M Hold
2,570
0.12% 77
2024
Q3
$1.59M Buy
2,570
+11
+0.4% +$6.51K 0.14% 68
2024
Q2
$1.42M Buy
+2,559
New +$1.47M 0.14% 73

Other funds holding TMO

Hardy Reed's TMO Position: Q1 2026 in Review

Hardy Reed reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $580K and leaving 4,027 shares worth $1.98M. The position accounts for 0.14% of the portfolio, ranked #63.

Hardy Reed first reported a position in TMO in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.95M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Hardy Reed held 4,027 shares of Thermo Fisher Scientific worth $1.98M as of Q1 2026.
  • Hardy Reed sold 1,069 Thermo Fisher Scientific shares in Q1 2026, an estimated $580K.
  • Thermo Fisher Scientific made up 0.14% of Hardy Reed's portfolio in Q1 2026, its #63 holding.
  • Hardy Reed first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 8 quarters since.
  • Hardy Reed's Thermo Fisher Scientific position peaked at $2.95M in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.